Neuphoria Therapeutics Reports Strong First Quarter 2025 Business Updates Amid Promising Stock Performance
Neuphoria Therapeutics Reports Strong First Quarter 2025 Business Updates Amid Promising Stock PerformanceBURLINGTON, Mass. May 20, 2025 – Neuphoria Therapeutics Inc. (Nasdaq: NEUP), a forward-thinking, clinical-stage b...
May 20, 2025
• Major Pharmaceutical Preparations Industry
Management Announcement
